The Masked Intruder: Rasburicase Unveiling Methemoglobinemia in Tumor Lysis Syndrome

被引：0
|
作者：
Peshin, Supriya [1 ]
Singal, Sakshi [2 ]
机构：
[1] Norton Community Hosp, Norton, MA USA
[2] East Tennessee State Univ, Johnson City, TN USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
case; b-cell lymphoma; methemoglobinemia; tumor lysis syndrome;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IBCL-802
引用
收藏
页码：S509 / S509
页数：1
相关论文
共 50 条
  • [31] Rasburicase and Tumor Lysis Syndrome: Lower Dosage, Consideration of Indications, and Hyperhydration Reply
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) : E69 - E69
  • [32] Impact of Early Rasburicase on Incidence and Outcomes of Clinical Tumor Lysis Syndrome in Lymphoma
    Personett, Heather A.
    Barreto, Erin F.
    McCullough, Kristen
    Dierkhising, Ross
    Leung, Nelson
    Habermann, Thomas M.
    BLOOD, 2018, 132
  • [33] Rasburicase: future directions in tumor lysis management
    Hochberg, Jessica
    Cairo, Mitchell S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (10) : 1595 - 1604
  • [34] Reduced administration of rasburicase for tumor lysis syndrome: A single-institution experience
    Takai, Mihoko
    Yamauchi, Takahiro
    Matsuda, Yasufumi
    Tai, Katsunori
    Ikegaya, Satoshi
    Kishi, Shinji
    Urasaki, Yoshimasa
    Yoshida, Akira
    Iwasaki, Hiromichi
    Ueda, Takanori
    ONCOLOGY LETTERS, 2015, 9 (05) : 2119 - 2125
  • [35] Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patients
    Eaddy, Michael
    Seal, Brian
    Tangirala, Muralikrishna
    Davies, Elizabeth Hackney
    O'Day, Ken
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (24) : 2110 - 2114
  • [36] Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults
    Yim, Barbara
    Navaleza, Anne
    Haidau, Augustin
    Sreenivasappa, Shylendra
    Kassem, Mohammed A.
    Ciobanu, Bety C.
    Braik, Tareq
    Gaddh, Manila
    Rubinstein, Paul G.
    Shah, Moushmi
    Telfer, Margaret
    Catchatourian, Rose
    BLOOD, 2010, 116 (21) : 741 - 742
  • [37] Rasburicase for the treatment of tumor lysis in hematological malignancies
    Malaguarnera, Giulia
    Giordano, Maria
    Malaguarnera, Mariano
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (01) : 27 - 38
  • [38] Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era
    Toda, Yumiko
    Ashizawa, Masahiro
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-Ichiro
    Nagayama, Takashi
    Umino, Kento
    Minakata, Daisuke
    Morita, Kaoru
    Yamamoto, Chihiro
    Hatano, Kaoru
    Sato, Kazuya
    Fujiwara, Shin-Ichiro
    Ohmine, Ken
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (06) : 660 - 666
  • [39] Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices
    Gilmore, Steven
    Carroll, Melissa
    Koselke, Elizabeth
    Hough, Shannon
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (05) : 867 - 872
  • [40] EFFICACY OF SINGLE DOSE RASBURICASE (1.5 MG) FOR PROPHYLAXIS AND MANAGEMENT OF TUMOR LYSIS SYNDROME
    Radhakrishnan, Venkatraman
    Philips, Ashwin
    PEDIATRIC BLOOD & CANCER, 2018, 65
12345